YAP1 and lung cancer: Our results indicate that a doxorubicin‐induced increase in TGFβ expression contributes to YAP‐dependent AXL induction in mesenchymal‐type lung cancer cells, suggesting that alterations in EMT lead to chemoresistance by enhancing YAP‐dependent survival gene responses.